Cancer

News

Merck KGaA and Pfizer break into cancer immunotherapy

Merck KGaA and Pfizer have got the fourth checkpoint inhibitor to market after the US regulator approved their avelumab for a rare form of skin cancer.

News

NHS faces a "Mission Impossible", say hospitals

Leaders must take action to prevent longer waits for ops and A&E treatment.

News

NICE rejects Darzalex, citing lack of clinical evidence

NICE has rejected Janssen’s Darzalex (daratumumab) for regular NHS funding in third line multiple myeloma, saying that gaps in clinical evidence mean cost-effectiveness data are unreliable.

News

Pharma attacks plan to ration new drugs in England

Plans to ration and delay use of novel drugs in England have been condemned by the pharma industry and a health charity.

News

AZ's Lynparza impresses with new ovarian cancer data

UK firm lays down the gauntlet in the PARP inhibitor battle.

News

NHS funding crisis affecting community services - report

Financial pressures on the health service are affecting community services, such as testing for sexually transmitted diseases and district nursing, according to a new report by The King’s F

Merck KGaA and Pfizer break into cancer immunotherapy

NHS faces a "Mission Impossible", say hospitals

NICE rejects Darzalex, citing lack of clinical evidence

Pharma attacks plan to ration new drugs in England

AZ's Lynparza impresses with new ovarian cancer data

NHS funding crisis affecting community services - report

An AI supercomputer and discovering next-gen brain disorder ...

How to meet your physicians where they are online

Cancer

Editor's Picks